Company: TELO
Filing Date: 2025-11-20
Form Type: PREM14A
Source: 0001493152-25-024463
Chunk: 63

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-11-20
Form: PREM14A
Chunk 63
---
 TELO, and current holders shares of TELO have interests in the Merger that may be different from, or in addition to, the interests of the TELO stockholders.

The TELO Board was aware of these potential conflicts of interest and considered them, among other matters, in reaching their respective decisions to approve the Merger Agreement and the Merger, and to recommend, as applicable, that TELO’s stockholders approve the proposals to be presented to TELO’s stockholders for consideration at the TELO Annual Meeting as contemplated by this proxy statement.

| 34 |

Ownership Interests

As of November 18, 2025, TELO’s directors and executive officers (including affiliates) beneficially owned, in the aggregate approximately 18.76% of the outstanding shares of TELI. Approval of Proposals No. 1 requires the affirmative vote of a majority of the votes cast virtually or by proxy at the TELI Annual Meeting.

Beneficial Ownership of TELI

Several beneficial owners of TELI, including holders of the Warrants, are also related parties of TELO. For example, TELO’s Chief Executive Officer, Erez Aminov, and owner of 6,411,200 shares of TELO also holds a beneficial ownership interest of 12,169,710 shares, or 25.02%, on a fully diluted basis, of TELI. Furthermore, shares of TELO are held by several trusts or individuals, also own shares of TELI. Specifically, (i) Bayshore Trust, holders of 5,406,431 shares of TELO, on a fully diluted basis, hold 20,798,767 shares of TELI, or 42.67% on a fully diluted basis, and (ii) the Celeste J Williams Lifetime QTIP Trust holds of 1,853,659 shares of TELO and 1,000,000, or 2.6% shares of TELI.

MIRALOGX LLC

Each of TELO and TELI license their respective intellectual property from MIRALOGX LLC. Such license agreements call for cash royalty payments to MIRALOGX that begin upon the first revenue realized from the licensed products and that continue thereafter regardless of whether further revenues are received from such licensed products.

Merger-Related Compensation of Executive Officers

In connection with the approval of the Merger, the Board previously adopted an Executive Compensation Plan that provides for certain performance-based compensation arrangements for executive